Jianfeng Group announced that its fully-owned subsidiary, Zhejiang Jianfeng Pharmaceutical Co., Ltd.'s controlled subsidiary, Zhejiang Erying Pharmaceutical Co., Ltd., received the "Pharmaceutical Registration Certificate" for Glass Sodium Hyaluronate Eye Drops issued and approved by China National Medical Products Administration.
尖峰集团：子公司获得玻璃酸钠滴眼液药品注册证书
Zhejiang Jianfeng Group: a subsidiary obtained a pharmaceutical registration certificate for glass sodium hyaluronate eye drops.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.